Botanical species · safety record

Leucojum vernum

The EFSA Compendium of Botanicals holds 16 constituent measurements for Leucojum vernum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Leucojum vernum L.

16Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
2-o-acetyllycorine	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
2-o-acetyllycorine	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Galanthamine	Bulb / clove	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Galanthamine	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Galanthamine	Bulb / clove	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Homolycorine	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lycorine	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Physostigmine	Bulb / clove	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Tazettine	Bulb / clove	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Homolycorine	Bulb / clove	Solvent extraction	—	—	No resolvable identifier
Lectins	Bulb / clove	—	—	—	No resolvable identifier
Lycorine	Bulb / clove	Solvent extraction	8 Percent	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

VANDAMME, EJM., ALLEN, AK., PEUMANS, WJ. RELATED MANNOSE-SPECIFIC LECTINS FROM DIFFERENT SPECIES OF THE FAMILY AMARYLLIDACEAE . Physiologia plantarum, 1988, vol. 73, no. 1, p. 52-57.
Boit, Hans G., Stender, Wolfgang. Alkaloids of the Amaryllidaceae. II. Alkaloids of Leucojum vernum and Narcissus poeticus var. ornatus. Chemische berichte, 1954, vol. 87, p. 681-3.
Marston, A., Kissling, J., Hostettmann, K. A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants . Phytochemical analysis, 2002, vol. 13, no. 1, p. 51-54. DOI
Forgo, P., Hohmann, J. Leucovernine and acetylleucovernine, alkaloids from Leucojum vernum. Journal of natural products, 2005, vol. 68, no. 11, p. 1588-1591. DOI
Szlavik, L., Gyuris, A., Minarovits, J., Forgo, P., Molnar, J., Hohmann, J. Alkaloids from Leucojum vernum and antiretroviral activity of amaryllidaceae alkaloids . Planta medica, 2004, vol. 70, no. 9, p. 871-873. DOI
Kalshnikov, I.D. Alkaloids of Leucojum vernum. Chemistry of natural compounds, 1974, vol. 10, no. 2, p. 274. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature